Varani et al. showed [28] that A2AR was upregulated in lymphocytes from early RA patients and A2AR activation inhibited the NF-kB pathway and decreased the expression of inflammatory cytokines such as TNF-α, IL-1β, and IL-6. This evidence concerns the gene ADORA2A and rheumatoid arthritis.